Navigation Links
Wyeth Pharmaceuticals Announces Organizational Change
Date:6/26/2008

- Andreas Krebs Named President of Europe/Middle East/Africa and Canada -

COLLEGEVILLE, Pa., June 26 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today the appointment of Andreas Krebs, 50, to President - Europe/Middle East/Africa and Canada, effective immediately. In this new role, Mr. Krebs will report to Joseph M. Mahady, President - Wyeth Pharmaceuticals, and Senior Vice President, Wyeth.

Mr. Krebs joined the Company in July 2003 as General Manager, Wyeth Germany, and since that time has worked to transform the German affiliate into one of the fastest growing companies in the market. He serves on the Board of the VFA (Germany's trade organization for research companies) and is a member of the Board of Trustees in the Max Planck Institute for Molecular Biomedicine and the Paul Ehrlich Society for Chemotherapy.

Prior to joining Wyeth, Mr. Krebs was with Bayer for approximately 20 years, where he held a variety of pharmaceutical marketing and sales leadership positions in Europe, Latin America, Asia and Canada. He holds a degree in Commercial Management and Business Administration from the In-House Academy of Woelm Pharma, Eschwege, Germany.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
2. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
3. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
4. Wyeth Chairman Robert Essner Announces June 27 Retirement
5. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
6. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
7. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
8. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
9. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
10. Wyeth Announces Executive Change in Finance Organization
11. Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... , Jan 13, 2017 Research and ... Product, Manufacturing, Application - Global Forecast to 2021" report to ... ... 2021 from USD 3.39 Billion in 2016, at a CAGR of ... the basis of product, manufacturing type, and application. Factors such as ...
(Date:1/13/2017)... ... January 13, 2017 , ... FireflySci has been ... found among its diverse customer base. The latest entry in this field is ... including BTX and Bio-Rad. FireflySci is introducing three distinct varieties including a 10x1mm, ...
(Date:1/12/2017)... ... January 12, 2017 , ... Each year, Crain’s Detroit Business News ranks ... that evaluates the patent estate of a company, its impact and significance, and the ... leading the way in technologies that transform energy sources such as low dose X-ray ...
(Date:1/12/2017)... ... January 12, 2017 , ... After ... Lisa Rosendahl’s doctors gave her only a few months to live. Now a ... that has stabilized Rosendahl’s disease and increased both the quantity and quality of ...
Breaking Biology Technology:
(Date:12/7/2016)... Dec. 7, 2016   Veridium , a ... appointment of new CEO James Stickland . ... decades of experience, has served in senior executive ... he specialized in expanding a pipeline of venture ... He most recently served as managing director of ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
(Date:12/5/2016)... 2016  The Office of Justice Programs, National ... Scans Enhance or Replace Medico Legal Autopsies?" on ... or replacing forensic autopsies with postmortem X-ray computed ... In response to recommendations made by The National ... scans as a potential component of medicolegal death ...
Breaking Biology News(10 mins):